Increase transparency across the prescription drug supply chain, including PBMs and manufacturers.

Increase transparency across the prescription drug supply chain, including Pharmacy Benefit Managers (PBMs), drug manufacturers, wholesalers, pharmacies, direct-to-consumer platforms, and pharmacy services administrative organizations, to expose opaque pricing practices and ensure affordable prices for patients.

The plan commits to transparency reforms in the drug supply chain.

Rep. Cisneros Unveils Health Care Action Plan | Representative Gil Cisneros
primary · press_release · model gpt-5.4-mini

unverified · Source version 51843 · locator unknown

"SEC. 6701. OVERSIGHT OF PHARMACY BENEFIT MANAGEMENT SERVICES." "shall submit to the group health plan a report in accordance with this section." "drug manufacturer, distributor, wholesaler, rebate aggregator (or other purchasing entity designed to aggregate rebates), or associated third party;"

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Public Law 119-75 enacted PBM reporting/disclosure provisions covering entities in the prescription drug supply chain, including manufacturers, distributors, wholesalers, and rebate aggregators. Because key requirements phase in later and are not universal across every supply-chain setting, this supports partial delivery.

partial same_term

Public Law 119-75, Consolidated Appropriations Act, 2026 | GovInfo
secondary · model gpt-5.5 · confidence 88%

unverified · Source version 51845 · locator unknown

"Vote Question: On Motion to Concur in the Senate Amendments" "Status: Passed" "Cisneros | Cisneros | Democratic | CA | Nay"

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The final House concurrence vote that sent H.R. 7148 toward enactment passed, but Cisneros voted Nay. This documents that the same-term policy outcome occurred without affirmative recorded vote effort from him on final passage.

partial same_term

Office of the Clerk, U.S. House of Representatives
secondary · model gpt-5.5 · confidence 85%